The data associated with this publication are not available for this reason: N/A
Abstract
Therapy-resistant cancer cells can be targeted using novel cationic amphiphilic drugs such as HMA that induce lysosomal cell death. Parallel alteration of lysosomal protein Saposin B could sensitize cells to HMA, reducing off-target effects.
